FYARRO vs HYFTOR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Attribute	FYARRO	HYFTOR
Rating	New	New
Pharmacy pays	~$48.61 /30	~$48.61 /30
Type	RX	RX
Active ingredient	SIROLIMUS	SIROLIMUS
Manufacturer	Aadi	Nobelpharma
Dosage forms	Injectable	Topical
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

fyarro hyftor

Rating

New

Pharmacy pays

~$48.61 /30

Type

Active ingredient

SIROLIMUS

Manufacturer

Aadi

Nobelpharma

Dosage forms

Injectable

Topical

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

Which is cheaper, Fyarro or Hyftor?

Pharmacies pay about the same to acquire either one — roughly $48.61 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Fyarro and Hyftor?

Both Fyarro and Hyftor share the active ingredient Sirolimus.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.